Generic Name and Formulations:
Neomycin 3.5mg, polymyxin B sulfate 10000Units/mL, dexamethasone 0.1%; oph. susp; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for MAXITROL:
Ocular inflammation associated with infection.
Severe: Initially 1–2 drops hourly. Mild: initially 1–2 drops up to 4–6 times daily. Ointment may be used adjunctively with drops at bedtime. Then prolong dosing interval as condition improves; max 20mL or 8g per therapeutic course.
<2yrs: not established.
Fungal, viral, or mycobacterial infections of the cornea and conjunctiva. Hypersensitivity to corticosteroids.
Not for injection. Corneal or scleral thinning. Glaucoma. Monitor for secondary infections and intraocular pressure in prolonged use. Aminoglycoside cross-sensitivity; discontinue if hypersensitivity develops. May mask signs of acute purulent or parasitic infection. Avoid abrupt cessation. Pregnancy. Nursing mothers.
Antibiotics + steroid.
Allergic sensitization, increased intraocular pressure, cataracts, corneal perforation, optic nerve damage, visual defects, delayed wound healing, bleb formation, allergic dermatitis.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Obesity, Male Gender May Improve Survival Outcomes with Targeted and Immunotherapy in Melanoma
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Travel Distance to Prostate Cancer Treatment Influences Treatment Choice
- Sexual Aids and Resources Not Readily Available at Cancer Centers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|